This practice note explains whether and how drug, medical device, biologics, and other life sciences companies should include alternative dispute resolution (ADR) mechanisms in their contracts to resolve commercial disputes.
Specifically, this practice note provides guidance on the following:
- Dispute Resolution Challenges in the Life Sciences Industry Addressed by ADR
- Common ADR Mechanisms in the Life Sciences Industry
- Finding the Right ADR Mechanism(s) for Your Life Sciences Contract
- Final Drafting Tips for ADR Clauses